|
Board of Directors
M. Ann Abbe
Mathew Bergman, Esq.
Robert B. Cameron, M.D.
Michael Harbut, M.D., M.P.H.
Ulf Jungnelius, M.D.
Susan Vento
Nicholas J. Vogelzang, M.D.
Mouzetta Zumwalt-Weathers
Roger G. Worthington, Esq.
In Memoriam
Congressman Bruce F. Vento
Bill Powell
Science Advisory Board
Steven Albelda, M.D.
Raphael Bueno, M.D.
Raffit Hassan, M.D.
Steve Hahn, M.D.
Hedy Lee Kindler, M.D.
Dan Miller, M.D.
Harvey Pass, M.D., Chairman
Lary A. Robinson, M.D.
Victor Roggli, M.D.
W. Roy Smythe, M.D.
Robert N. Taub, M.D.
Joseph R. Testa, Ph.D.
Eric Vallieres, M.D.
Claire Verschraegen, M.D.
Executive Director
Christopher E. Hahn
MARF, inc.
1123 Chapala Street
2nd Floor
PO Box 91840
Santa Barbara, CA 93190-1840
tel: (805) 560-8942
fax: (805) 560-8962
http://www.marf.org
|
Our Mission is to eradicate mesothelioma as a
life-ending disease.
Federal Mesothelioma Research Funding Petition
Statement
February 4, 2005
Mesothelioma (meso) is an asbestos-related cancer that
painfully and aggressively invades the lining of the lungs,
abdomen, heart or testicles. For decades, the need to
develop treatments for mesothelioma was overlooked. As a
result, today's standard treatments usually have only a
very limited effect and the average survival time is only 4
to 14 months.
Meso kills thousands of Americans each year, and its
incidence is rising. For decades asbestos was used heavily
in Navy ships and shipyards, in industrial workplaces, and
in the construction of our buildings, schools, and homes.
Meso has a long latency (30 years average) and most at risk
are millions of U.S. workers and servicemen who were
exposed almost daily over long periods of time. When they
brought the fibers home each night on their hair, skin and
clothes, their wives and children were exposed too.
But even short-term, low exposures can cause the disease,
and Americans continue to be put at risk today. The EPA
estimates that asbestos is present in as many as 30 million
U.S. homes. It still has not been banned in the U.S. and is
used in over 3,000 products. Hundreds of tons were released
into New York's air from the collapse of the World
Trade Center on 911. At least 100,000 firefighters, police
officers, rescue workers and New York City residents,
workers and school children were likely exposed to
dangerous levels.
Therefore, to limit future suffering and death caused by
meso, The Mesothelioma Applied Research Foundation
recommends the establishment of a National Mesothelioma
Research and Treatment Program (NMRTP), federally funded at
$30 million per year. Experts believe that with appropriate
resources, effective means to treat meso, and/or to detect
it early and prevent it, are within reach. Currently,
there are no federal dollars specifically allocated for
mesothelioma research, even though one third of
mesothelioma patients were exposed in U.S. Navy ships and
shipyards.
The NMRTP would function primarily through ten mesothelioma
centers located strategically throughout the country. The
NMRTP's first priority would be to move forward on
exciting advances being made in early detection and
prevention.
The second priority would be research to improve treatments
for, and ultimately cure, mesothelioma. This includes all
of the novel surgical, chemotherapeutic, radiation, and
biologic strategies now being pursued. It also includes a
registry and tissue bank. Unlike most European nations, the
U.S. does not maintain a comprehensive registry for
mesothelioma as a reportable disease.
The final priority is education. Public awareness of
mesothelioma must increase. More young investigators and
clinicians must be trained. Meso patients, their family
members and their local physicians need accessible,
up-to-date information on newly available treatments, on
managing pain and side effects, and on coping with this
cruel disease.
My signature below indicates that I support The
Mesothelioma Applied Research Foundation's work to
establish a National Mesothelioma Research and
Treatment Program, federally funded at $30 million per
year.
|
___________________________________________________________
|
|
__________________
|
|
[name]
|
|
[date]
|
|
|
|
|
________________________________________________________________________________
[street number, city and state]
|
|